Dr. Jaffar A. Raza, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 33
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 412
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
NJ license 25MA08523600 -
Cardiovascular Disease Physician
NJ license 25MA08523600 -
Nuclear Cardiology Physician
NJ license 25MA08523600
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Holy Name Medical Center Teaneck, NJ
Medical groups
- Excelcare Medical Associates PA (205 clinicians)
- Optum Medical Care of New Jersey PC (163 clinicians)
- Holy Name Hospital Ekg Interpretation Group (13 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 412
- Services billed
- 2,363
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 375 | 22 |
| Established patient office or other outpatient visit, 30-39 minutes | 365 | 214 |
| Established patient office or other outpatient visit, 20-29 minutes | 274 | 174 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 225 | 180 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 103 | 102 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 85 | 81 |
| Ultrasound of leg arteries or artery grafts | 56 | 54 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 52 | 39 |
| New patient office or other outpatient visit, 45-59 minutes | 40 | 40 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 34 | 31 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Teaneck, NJ | 371 |
| Amlodipine Besylate Other prescribers in Teaneck, NJ | 336 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Teaneck, NJ | 330 |
| Metoprolol Succinate Other prescribers in Teaneck, NJ | 251 |
| Rosuvastatin Calcium Other prescribers in Teaneck, NJ | 218 |
| Carvedilol Other prescribers in Teaneck, NJ | 181 |
| Nifedipine Er (nifedipine) Other prescribers in Teaneck, NJ | 146 |
| Losartan-Hydrochlorothiazide (losartan/hydrochlorothiazide) Other prescribers in Teaneck, NJ | 130 |
| Eliquis (apixaban) Other prescribers in Teaneck, NJ | 115 |
| Lisinopril Other prescribers in Teaneck, NJ | 113 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 10 companies reported 52 payments worth $11,529 in total to this clinician.
| Recor Medical Inc | $8,836 |
|---|---|
| Abbott Laboratories | $1,877 |
| Boston Scientific Corporation | $338 |
| Amgen Inc. | $109 |
| Vivaquant Inc, DBA Rhythm Express | $97.70 |
| Heartflow, Inc. | $84.29 |
| Shockwave Medical, Inc | $71.66 |
| Merck Sharp & Dohme LLC | $46.60 |
| Consulting Fee | $7,000 |
|---|---|
| Food and Beverage | $2,628 |
| Travel and Lodging | $1,875 |
| Education | $25.70 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Recor Medical Inc Nov 4, 2025 | Consulting Fee Paradise Ultrasound Renal Denervation System · Devices | $4,500 |
| Recor Medical Inc Nov 4, 2025 | Consulting Fee Paradise Ultrasound Renal Denervation System · Devices | $2,500 |
| Recor Medical Inc Aug 26, 2025 | Travel and Lodging Paradise Ultrasound Renal Denervation System · Devices · travel to Newark, NJ · in-kind | $583 |
| Recor Medical Inc Sep 12, 2025 | Travel and Lodging Paradise Ultrasound Renal Denervation System · Devices · travel to Chicago, IL · in-kind | $398 |
| Abbott Laboratories Nov 20, 2025 | Travel and Lodging PERCLOSE PROGLIDE · Structural Heart · travel to New York, NY · in-kind | $347 |
| Abbott Laboratories Nov 20, 2025 | Travel and Lodging PERCLOSE PROGLIDE · Structural Heart · travel to New York, NY · in-kind | $347 |
| Recor Medical Inc Nov 4, 2025 | Travel and Lodging Paradise Ultrasound Renal Denervation System · Devices · travel to Chicago, IL | $202 |
| Merck Sharp & Dohme LLC Dec 2, 2025 | Education in-kind | $25.70 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $463,219 in research payments for these studies, mostly to the institutions running them.
- TRANSFORM
Cleerly, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.